Results 231 to 240 of about 45,062 (281)
Some of the next articles are maybe not open access.

IC51 Japanese Encephalitis vaccine

Expert Opinion on Biological Therapy, 2009
Japanese encephalitis is the leading cause of viral encephalitis in Asia. Every year 30,000 - 50,000 cases and 10,000 deaths from Japanese encephalitis are reported, and underreporting has been suggested. No effective antiviral therapy exists to treat this mosquito-borne flavivirus infection. For active immunization vaccines are available.
Herwig, Kollaritsch   +2 more
openaire   +2 more sources

[Japanese encephalitis vaccine].

Nihon rinsho. Japanese journal of clinical medicine, 2011
Japanese encephalitis is a mosquito-borne flaviviral infection, which has a wide distribution in Asian countries, including Japan. The clinical illness may manifest as a febrile headache syndrome, aseptic meningitis, or encephalitis with a number of cases of subclinical infection. Japanese encephalitis is a vaccine-preventable disease.
openaire   +3 more sources

Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated Japanese encephalitis vaccine.

International Journal of Biological Macromolecules, 2021
Ekachai Dumkliang   +6 more
semanticscholar   +1 more source

Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.

Vaccine, 2021
S. Khan   +6 more
semanticscholar   +1 more source

New Vaccines for Japanese Encephalitis

Current Infectious Disease Reports, 2010
Epidemics of encephalitis occurring throughout much of Asia are caused by Japanese encephalitis virus (JEV), a flavivirus maintained in a zoonotic cycle and transmitted by the mosquito, Culex tritaeniorhynchus. Resident populations, including short-or long-term visitors to enzootic regions, are at risk for Japanese encephalitis (JE) infection and ...
Scott B, Halstead, Stephen J, Thomas
openaire   +2 more sources

Designing spatial and temporal control of vaccine responses

Nature Reviews Materials, 2021
Shih Hao Ou, Wei Luo, Bali Pulendran
exaly  

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology, 2021
Aakash Desai   +2 more
exaly  

SARS-CoV-2 variants, spike mutations and immune escape

Nature Reviews Microbiology, 2021
William T Harvey   +2 more
exaly  

Home - About - Disclaimer - Privacy